Standard Chem & Pharm Co Ltd
TWSE:1720

Watchlist Manager
Standard Chem & Pharm Co Ltd Logo
Standard Chem & Pharm Co Ltd
TWSE:1720
Watchlist
Price: 64.4 TWD 1.26% Market Closed
Market Cap: 11.5B TWD
Have any thoughts about
Standard Chem & Pharm Co Ltd?
Write Note

Standard Chem & Pharm Co Ltd
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Standard Chem & Pharm Co Ltd
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Standard Chem & Pharm Co Ltd
TWSE:1720
Cash from Investing Activities
-NT$674m
CAGR 3-Years
-6%
CAGR 5-Years
-55%
CAGR 10-Years
-4%
Y
YungShin Global Holding Corp
TWSE:3705
Cash from Investing Activities
-NT$334.3m
CAGR 3-Years
N/A
CAGR 5-Years
8%
CAGR 10-Years
6%
Formosa Laboratories Inc
TWSE:4746
Cash from Investing Activities
-NT$1.5B
CAGR 3-Years
-34%
CAGR 5-Years
-6%
CAGR 10-Years
-11%
ScinoPharm Taiwan Ltd
TWSE:1789
Cash from Investing Activities
-NT$280.3m
CAGR 3-Years
-103%
CAGR 5-Years
-128%
CAGR 10-Years
15%
S
SCI Pharmtech Inc
TWSE:4119
Cash from Investing Activities
-NT$763.7m
CAGR 3-Years
-23%
CAGR 5-Years
-22%
CAGR 10-Years
-4%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Cash from Investing Activities
-NT$1.5B
CAGR 3-Years
-9%
CAGR 5-Years
8%
CAGR 10-Years
N/A
No Stocks Found

Standard Chem & Pharm Co Ltd
Glance View

Market Cap
11.5B TWD
Industry
Pharmaceuticals

Standard Chemical & Pharmaceutical Co., Ltd. engages in the manufacture and sale of Chinese and western medicine, medicine raw materials, and health food. The company is headquartered in Tainan, Tainan. The Company’s products cover drugs for circulation systems, digest systems, respiratory systems, nervous systems and other diseases. Through its subsidiaries, the Company is also engaged in the sales of medical equipment, animal medicine, milk powder, cosmetics and others. The firm distributes its products both in domestic markets and overseas markets.

Intrinsic Value
96.28 TWD
Undervaluation 33%
Intrinsic Value
Price

See Also

What is Standard Chem & Pharm Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-674m TWD

Based on the financial report for Jun 30, 2024, Standard Chem & Pharm Co Ltd's Cash from Investing Activities amounts to -674m TWD.

What is Standard Chem & Pharm Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-4%

Over the last year, the Cash from Investing Activities growth was -230%. The average annual Cash from Investing Activities growth rates for Standard Chem & Pharm Co Ltd have been -6% over the past three years , -55% over the past five years , and -4% over the past ten years .

Back to Top